Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

Descrizione completa

Dettagli Bibliografici
Autori principali:	A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Natura:	Articolo
Lingua:	Russian
Pubblicazione:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Serie:	Проблемы особо опасных инфекций
Soggetti:	вирус эбола лекарственные средства экстренная профилактика и лечение вирусспецифические антитела моноклональные антитела малые интерферирующие рнк антисмысловые фосфордиамидатные морфолиновые олигомеры ebola virus hemorrhagic fever medical products emergency prophylaxis and treatment virus-specific antibodies monoclonal antibodies small interfering rna anti-sense phosphordiamidate morpholine oligomers
Accesso online:	https://journal.microbe.ru/jour/article/view/254

Documenti analoghi

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
di: E. I. Kazachinskaya, et al.
Pubblicazione: (2015-09-01)

“CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
di: Alexey Alekseevich Andreev, et al.
Pubblicazione: (2020-06-01)

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
di: A. A. Petrov, et al.
Pubblicazione: (2020-05-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
di: A. A. Sominina, et al.
Pubblicazione: (2015-10-01)

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
di: A. V. Philippova, et al.
Pubblicazione: (2019-10-01)

Preparations of next generation monoclonal antibodies (issues and prospects)
di: Zh. I. Avdeeva, et al.
Pubblicazione: (2018-02-01)

SMALL NONCODING RNA AS PERSPECTIVE BIOMARKERS: BIOGENESIS AND THERAPEUTIC STRATIGIES
di: V. V. Tiguntsev, et al.
Pubblicazione: (2016-06-01)

Obtainment of Monoclonal Antibodies and Prospects of Their Application as Basis for Immunodiagnostic Aids for Crimean-Congo Hemorrhagic Fever Virus Detection
di: N. P. Khrapova, et al.
Pubblicazione: (2015-03-01)

Safety issues of monoclonal antibodies used in rheumatology
di: A. V. Philippova, et al.
Pubblicazione: (2020-01-01)

The Molecular Genetic Peculiarities of Genomic Structure of Members of the <i>Ebolavirus</i> Genus
di: A. A. Petrov, et al.
Pubblicazione: (2015-09-01)

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens
di: O. O. Fomenkov, et al.
Pubblicazione: (2015-06-01)

Study of protectivity and antigenicity of vaccine based on ' cultural Asia-1 No.2145/ Tajikistan/2011 FMD Virus
di: D. A. Lozovoy, et al.
Pubblicazione: (2018-04-01)

Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection
di: N. E. Tereshkina, et al.
Pubblicazione: (2013-06-01)

SEROPREVALENCE OF INFECTIOUS BURSAL DISEASE VIRUS IN PRIVATE POULTRY BREEDINGS OF UKRAINE FROM 2014 TO 2016
di: А. С. Пастиря, et al.
Pubblicazione: (2017-06-01)

Utilization of Immunoblotting in Studies of Epitope Targeting in Monoclonal Antibodies to Melioidosis Agent Antigen 200 kDa
di: I. I. Korsakova, et al.
Pubblicazione: (2014-12-01)

Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease
di: T. E. Sizikova, et al.
Pubblicazione: (2015-09-01)

Diagnosis of hepatitis c today and interpretation of infection markers
di: T. V. Kozhanova
Pubblicazione: (2013-12-01)

Antidiphtheria immunity at children with allergic diseases
di: A V Labushkina, et al.
Pubblicazione: (2009-12-01)

Pharmacokinetic properties of the preparations of protein origin
di: A. A. Soldatov, et al.
Pubblicazione: (2018-02-01)

Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I
di: N. V. Bogacheva, et al.
Pubblicazione: (2016-06-01)

Validation of the technique aimed at the determination of FMD antibodies in liquid phase blocking sandwich Elisa
di: N. N. Lugovskaya, et al.
Pubblicazione: (2018-04-01)

Возможности сочетания иммунотерапии с лучевой терапией в лечении больных неоперабельным местно-распространённым немелкоклеточным раком легкого. Обзор литературы.
Pubblicazione: (2021-06-01)

Сравнительная эффективность и безопасность применения препаратов моноклональных антител к ИЛ-6 у пациентов с новой коронавирусной инфекцией COVID-19 тяжелого течения. Ретроспективное когортное исследование
di: С. С. Бобкова, et al.
Pubblicazione: (2021-03-01)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review
di: D. L. Klabukova, et al.
Pubblicazione: (2018-07-01)

Метод РНК-интерференции в защите растений от насекомых-вредителей
di: Владимир Сергеевич Журавлев, et al.
Pubblicazione: (2022-04-01)

Validation of the XTT-test for assessing the antiproliferative activity of biologics on the basis of monoclonal antibodies
di: I. V. Lyagoskin, et al.
Pubblicazione: (2018-02-01)

FREQUENCY OF OCCURRENCE OF ANTIBODIES TO HLA ANTIGENS IN RECIPIENTS ON THE WAITING LIST FOR KIDNEY TRANSPLANTATION
di: Елена Борисовна Лукоянычева, et al.
Pubblicazione: (2023-02-01)

The morphological changes dynamics of ovarian reproductive apparatus in the experimental autoimmune oophoritis
di: M. L. Dmitriyeva, et al.
Pubblicazione: (2012-02-01)

The Value of the Effect of the Level of Specific Antibodeis on Elimination Different Tick-Borne Encephalitis Virus Strains
di: G. N. Leonova, et al.
Pubblicazione: (2017-04-01)

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development
di: A. A. Lidzhieva, et al.
Pubblicazione: (2018-02-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
di: N. T. Tikhonova, et al.
Pubblicazione: (2017-12-01)

Construction and Investigation of the Variants of the Vaccine Strain <I>Francisella tularensis</I> Lacking <I>iglC </I>Genes. Communication 2
di: A. N. Mokrievich, et al.
Pubblicazione: (2013-12-01)

Donor – recipient selection using epitope mismatches in kidney transplantation
di: A. V. Vatazin, et al.
Pubblicazione: (2021-01-01)

Improvement of Diagnostic System in a Real-Time RT-PCR “AmpliSens EBOV (ZAIRE)-FL” Format for Zaire ebolavirus RNA Detection
di: V. G. Dedkov, et al.
Pubblicazione: (2015-09-01)

Construction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
di: L. Yu. Aksenova, et al.
Pubblicazione: (2013-12-01)

Antikeratin antibodies in rheumatoid arthritis
di: J Zabek
Pubblicazione: (2003-02-01)

Заболявания, свързани с анти-миелинови олигодендроцитни гликопротеинови антитела (MOG-antibody diseases)
di: Sonia Ivanova, et al.
Pubblicazione: (2019-09-01)

The possible role of toxoplasmosis in the development of antiphospholipid antibodies in pregnancy-related complications
di: - Bayati Ali Hattem Hussein, et al.
Pubblicazione: (2012-09-01)

Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
di: A. A. Lopatin, et al.
Pubblicazione: (2015-09-01)

Future Developments and Applications of the Vaccines against Dangerous Viral Infections, RNA-Replicon-Based, Obtained from the Venezuelan Equine Encephalomyelitis Virus
di: A. A. Petrov, et al.
Pubblicazione: (2014-09-01)